Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells

Vaccine

Volumn 29, Issue 16, 2011, Pages 2902-2909

  Derrick, Steven C ^a   Yabe, Idalia M ^a   Yang, Amy ^a   Morris, Sheldon L ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

BCG; Cytokines; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; FEMALE; IMMUNITY; IMMUNOGENICITY; LUNG TUBERCULOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS CONTROL;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953189362     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.010     Document Type: Article

References (32)

1. World Health Organization The top 10 causes of death. Fact sheet 310 2008, http://www.who.int/mediacentre/factsheet/fs310/en/.
2. Dye C. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol 2009, 7(1):81-87.
3. Vitoria M., Granich R., Gilks C.F., Gunneberg C., Hosseini M., Were W., et al. The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. Am J Clin Pathol 2009, 131(6):844-848.
4. Glaziou P., Floyd K., Raviglione M. Global burden and epidemiology of tuberculosis. Clin Chest Med 2009, 30(4):621-636. vii.
5. Cooper A.M. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009, 27:393-422.
6. Johnson L., Gough J., Spencer Y., Hewinson G., Vordermeier M., Wangoo A. Immunohistochemical markers augment evaluation of vaccine efficacy and disease severity in bacillus Calmette-Guerin (BCG) vaccinated cattle challenged with Mycobacterium bovis. Vet Immunol Immunopathol 2006, 111(3-4):219-229.
7. Palma C., Iona E., Giannoni F., Pardini M., Brunori L., Orefici G., et al. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice. Cell Microbiol 2007, 9(6):1455-1465.
8. Darrah P.A., Patel D.T., De Luca P.M., Lindsay R.W., Davey D.F., Flynn B.J., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against leishmania major. Nat Med 2007, 13(7):843-850.
9. Forbes E.K., Sander C., Ronan E.O., McShane H., Hill A.V., Beverley P.C., et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 2008, 181(7):4955-4964.
10. Huaman M.C., Mullen G.E., Long C.A., Mahanty S. Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells. Vaccine 2009, 27(38):5239-5246.
11. Lindenstrom T., Agger E.M., Korsholm K.S., Darrah P.A., Aagaard C., Seder R.A., et al. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 2009, 182(12):8047-8055.
12. Yamamoto T., Iwamoto N., Yamamoto H., Tsukamoto T., Kuwano T., Takeda A., et al. Polyfunctional CD4+ T-cell induction in neutralizing antibody-triggered control of simian immunodeficiency virus infection. J Virol 2009, 83(11):5514-5524.
13. Kannanganat S., Ibegbu C., Chennareddi L., Robinson H.L., Amara R.R. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 2007, 81(16):8468-8476.
14. Kannanganat S., Kapogiannis B.G., Ibegbu C., Chennareddi L., Goepfert P., Robinson H.L., et al. Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J Virol 2007, 81(21):12071-12076.
15. Genesca M., Rourke T., Li J., Bost K., Chohan B., McChesney M.B., et al. Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239. J Immunol 2007, 179(7):4732-4740.
16. Seder R.A., Darrah P.A., Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008, 8(4):247-258.
17. Beveridge N.E., Price D.A., Casazza J.P., Pathan A.A., Sander C.R., Asher T.E., et al. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol 2007, 37(11):3089-3100.
18. Scriba T.J., Tameris M., Mansoor N., Smit E., van der Merwe L., Isaacs F., et al. Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol 2010, 40(1):279-290.
19. Soares A.P., Scriba T.J., Joseph S., Harbacheuski R., Murray R.A., Gelderbloem S.J., et al. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 2008, 180(5):3569-3577.
20. Derrick S.C., Yang A.L., Morris S.L. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 2004, 23(6):780-788.
21. Parra M., Yang A.L., Lim J., Kolibab K., Derrick S., Cadieux N., et al. Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis. Clin Vaccine Immunol 2009, 16(7):1025-1032.
22. Kolibab K., Yang A., Derrick S.C., Waldmann T.A., Perera L.P., Morris S.L. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant. Clin Vaccine Immunol 2010, 17(5):793-801.
23. Lenardo M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991, 353:858-861.
24. Ha S.A., West E.E., Araki K., Smith K.A., Ahem R. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunol Rev 2008, 223:317-333.
25. Hawkridge T., Scriba T.J., Gelderbloem S., Smit E., Tameris M., Moyo S., et al. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis 2008, 198(4):544-552.
26. Sui Y., Zhu Q., Gagnon S., Dzutsev A., Terabe M., Vaccari M., et al. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc Natl Acad Sci U S A 2010, 9843-9848.
27. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003, 9(9):1131-1137.
28. Dietrich J., Billeskov R., Doherty T.M., Andersen P. Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection. J Immunol 2007, 178(6):3721-3730.
29. Wedlock D.N., Denis M., Painter G.F., Ainge G.D., Vordermeier H.M., Hewinson R.G., et al. Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clin Vaccine Immunol 2008, 15(5):765-772.
30. Maue A.C., Waters W.R., Palmer M.V., Nonnecke B.J., Minion F.C., Brown W.C., et al. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 2007, 25(24):4735-4746.
31. Skinner M.A., Wedlock D.N., de Lisle G.W., Cooke M.M., Tascon R.E., Ferraz J.C., et al. The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis. Infect Immun 2005, 73(7):4441-4444.
32. Kagina B.M., Abel B., Scriba T.J., Hughes E.J., Keyser A., Keyser A., et al. Specific T cell frequency of cytokine expression profile do not correlate with protection against tuberculosis, following BCG vaccination of newborns. AJRCCM 2010.